PLX (PROTALIX BIOTHERAPEUTICS INC) — 3 tracked funds

Cross-fund · 3 holders

PLX

PROTALIX BIOTHERAPEUTICS INC

CUSIP 74365A309

Tracked holders

$8.9M

Aggregate value

4,175,114

Active funds

Funds holding PLX

Fund	Strategy	Period	Value	% of book	Δ shares	Status
BlackRock	Institutional	Q1 2026	$7.8M	—	-30,144	-0.8%
Vanguard	Institutional	Q4 2025	$879,393	—	+24,131	+5.2%
Citadel	Multi-Strategy	Q1 2026	$151,032	—	-292,628	-80.8%

Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.